Your session is about to expire
← Back to Search
Delirium Education, Prevention, and Management for ICU Delirium
Study Summary
This trial will test whether educating families on delirium prevention, detection, and management will improve patient and family outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the ultimate aim of this clinical trial?
"This trial's principal aim is to assess the alteration in generalized anxiety symptomatology among family members of critically ill patients over a 3-month period post discharge, with Generalized Anxiety Disorder-7 (GAD-7) being used as an evaluative tool. Secondary outcomes include alterations in delirium severity levels as quantified by Intensive Care Delirium Screening Checklist scores pre and post intervention, retrospective review for patient delirium within medical charts, and changes in prevalence of said condition measured through ICDSC evaluations prior to treatment commencement."
Are there openings available for participants in this experiment?
"Indeed, clinicaltrials.gov data confirms that this medical experiment is actively recruiting individuals. The trial was first published on January 13th 2020 and the most recent amendment was made October 7th 2021; 198 people need to be recruited from 4 different locations."
How many participants are engaged in the experiment?
"Affirmative. Clinicaltrials.gov's information confirms that this clinical trial, which was initially published on January 13th of 2020, is still recruiting patients. A total of 198 participants must be enlisted from 4 distinct locations."
Share this study with friends
Copy Link
Messenger